JPM UK Equity Growth Fund C - Net IncomeRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -5.0 | 19.3 | -12.9 | 11.4 | 12.1 | |
+/-Cat | 0.0 | 3.0 | -1.2 | 3.4 | 5.4 | |
+/-B’mrk | - | - | - | 3.8 | 3.9 | |
Category: UK Flex-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 21/11/2024 | GBP 2.12 | |
Day Change | -0.14% | |
Morningstar Category™ | UK Flex-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | GB00B3FJQH18 | |
Fund Size (Mil) 20/11/2024 | GBP 152.89 | |
Share Class Size (Mil) 20/11/2024 | GBP 3.59 | |
Max Initial Charge | - | |
Ongoing Charge 01/01/2024 | 0.90% |
Investment Objective: JPM UK Equity Growth Fund C - Net Income |
To provide capital growth over the long-term (5-10 years) by investing at least 80% of the Fund's assets in a growth style biased portfolio of UK companies. At least 80% of assets invested in a growth style biased portfolio of equities of companies that are domiciled, or carrying out the main part of their economic activity, in the UK. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Guy Anderson 31/05/2021 | ||
Manasij Hajra 01/02/2023 | ||
Inception Date 20/08/2012 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE All Share NR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for JPM UK Equity Growth Fund C - Net Income | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 5.68 |
Unilever PLC | Consumer Defensive | 5.54 |
Shell PLC | Energy | 5.06 |
3i Group Ord | 4.30 | |
HSBC Holdings PLC | Financial Services | 3.66 |
Increase Decrease New since last portfolio | ||
JPM UK Equity Growth Fund C - Net Income |